Chancellor Financial Group WB LP Acquires Shares of 2,861 Danaher Corporation $DHR

Chancellor Financial Group WB LP bought a new stake in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,861 shares of the conglomerate’s stock, valued at approximately $545,000.

A number of other large investors have also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. increased its holdings in Danaher by 303.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after purchasing an additional 186,584 shares during the period. Legal & General Group Plc lifted its holdings in shares of Danaher by 1.0% in the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after buying an additional 43,169 shares during the period. Advisors Capital Management LLC grew its position in shares of Danaher by 14.0% during the 4th quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock worth $12,555,000 after buying an additional 6,720 shares in the last quarter. Handelsbanken Fonder AB grew its position in shares of Danaher by 10.9% during the 2nd quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock worth $55,091,000 after buying an additional 28,425 shares in the last quarter. Finally, Swiss Life Asset Management Ltd increased its stake in shares of Danaher by 12.1% during the fourth quarter. Swiss Life Asset Management Ltd now owns 115,335 shares of the conglomerate’s stock valued at $26,402,000 after buying an additional 12,416 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Up 6.2%

Shares of NYSE:DHR opened at $211.92 on Thursday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm has a market capitalization of $148.98 billion, a P/E ratio of 37.64, a P/E/G ratio of 2.49 and a beta of 0.78. The business’s 50-day moving average is $194.30 and its 200 day moving average is $192.44. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the previous year, the firm earned $0.77 earnings per share. The company’s revenue was up 5.5% on a year-over-year basis. On average, research analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on DHR. Citigroup assumed coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. TD Cowen cut their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Evercore restated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Morgan Stanley lowered their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Finally, Piper Sandler initiated coverage on shares of Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective on the stock. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.